The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Nausea — NHS UK Guide
Nausea is one of the most common side effects of Mounjaro (tirzepatide), a prescription-only GLP-1 receptor agonist weight loss injection licensed in the UK. If you've been prescribed Mounjaro through an NHS specialist weight management service or private clinical assessment, understanding what to expect with nausea — how likely it is, how long it typically lasts, and what you can do about it — helps you manage the side effect confidently. This guide covers nausea management based on UK NHS guidance and clinical trial data.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Common Is Mounjaro Nausea?
Nausea is classified as a very common side effect of Mounjaro, affecting more than 1 in 10 people in clinical trials. In the SURMOUNT-1 trial, nausea occurred in approximately 25% of participants at the highest dose (15 mg weekly). The severity and frequency vary considerably between individuals — some experience mild nausea, while others find it more pronounced.
Nausea is most common when starting Mounjaro or increasing your dose. It typically peaks in the first few weeks on a new dose, then gradually improves as your body adjusts to the medication. Most people find the nausea becomes manageable within 2–4 weeks of starting or escalating, though this timeline varies. If you're experiencing persistent nausea after 4 weeks on the same dose, contact your prescriber or GP — they may adjust your dose schedule or recommend management strategies.
Your prescriber should have discussed nausea as a possible side effect during your clinical assessment before issuing your prescription.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Managing Mounjaro Nausea — NHS-Aligned Strategies
Dietary adjustments are the first-line approach recommended by NHS specialists. Eat smaller, more frequent meals rather than large ones; choose bland, easily digestible foods (toast, rice, lean chicken); and avoid fatty or heavily spiced meals which can worsen nausea. Stay hydrated with water or sugar-free drinks. Avoid eating too quickly.
If nausea persists despite dietary changes, your GP or prescriber may recommend anti-nausea medication (such as ondansetron or metoclopramide) as a short-term support while your body adjusts. Never take over-the-counter nausea remedies without checking with your GP or pharmacist first — some can interact with Mounjaro. Our GLP-1 weight loss calculator can help you track how you're responding to your current dose alongside side effect management.
Contact your GP or prescriber if nausea is severe, prevents you eating or drinking, lasts longer than a few weeks, or is accompanied by vomiting or abdominal pain. These could indicate a more serious condition requiring urgent assessment. Never stop Mounjaro without medical guidance — your prescriber will advise on next steps, which may include dose adjustment, temporary pause, or switching to an alternative medication. Keeping a simple log of when nausea occurs and what triggers it can help your healthcare team tailor your management plan.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
How long does Mounjaro nausea usually last?
Most people experience nausea for the first 2–4 weeks after starting or increasing their dose, then improvement occurs as the body adjusts. Some people find it resolves within days; others may experience it for longer. If nausea persists beyond 4 weeks on the same dose, speak to your prescriber about management options or dose adjustment.
Is Mounjaro nausea a sign it's working?
Not necessarily. Nausea is a common side effect of the medication itself, not an indicator of weight loss effectiveness. Some people lose weight without significant nausea, while others experience nausea but modest weight loss. If you're concerned about your response to Mounjaro, discuss this with your prescriber — they can assess your progress objectively.
Can I take anti-nausea tablets with Mounjaro?
Yes, but only on medical advice. Your GP or prescriber may recommend short-term anti-nausea medication (such as ondansetron) while you adjust to Mounjaro. Always inform your prescriber of all medications you're taking — some can interact with tirzepatide or affect how it works. Never self-treat nausea without checking first.
Should I stop Mounjaro if I have severe nausea?
No — do not stop without medical guidance. Contact your GP or prescriber immediately if nausea is severe, prevents you eating or drinking, or lasts longer than expected. Your prescriber may adjust your dose, temporarily pause treatment, or recommend management strategies. They can also rule out other causes of nausea.
Does nausea mean Mounjaro isn't right for me?
Not necessarily. Nausea is a very common short-term side effect that often improves as your body adjusts. Many people who experience initial nausea continue with Mounjaro successfully once the side effect settles. Your prescriber will help you decide whether continuing is right for you based on your overall tolerability and weight loss progress.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.